New cytotoxic agents: a review of the literatureHOTTA, Katsuyuki; UEOKA, Hiroshi.Critical reviews in oncology/hematology. 2005, Vol 55, Num 1, pp 45-65, issn 1040-8428, 21 p.Article

An overview of 48 elderly-specific clinical trials of systemic chemotherapy for advanced non-small cell lung cancerHOTTA, Katsuyuki; UEOKA, Hiroshi; KIURA, Katsuyuki et al.Lung cancer. 2004, Vol 46, Num 1, pp 61-76, issn 0169-5002, 16 p.Article

Association of the benefit from gefitinib monotherapy with smoking status in Japanese patients with non-small-cell lung cancerHOTTA, Katsuyuki; KIURA, Katsuyuki; TAKIGAWA, Nagio et al.Lung cancer. 2008, Vol 62, Num 2, pp 236-241, issn 0169-5002, 6 p.Article

Being overweight influences the development of hepatic dysfunction in Japanese patients with non-small-cell lung cancer undergoing cytotoxic chemotherapyFUJIWARA, Yoshiro; KIURA, Katsuyuki; HOTTA, Katsuyuki et al.Lung cancer. 2007, Vol 55, Num 3, pp 343-348, issn 0169-5002, 6 p.Article

Meta-analysis of randomized clinical trials comparing cisplatin to carboplatin in patients with advanced non-small-cell lung cancerHOTTA, Katsuyuki; MATSUO, Keitaro; UEOKA, Hiroshi et al.Journal of clinical oncology. 2004, Vol 22, Num 19, pp 3852-3859, issn 0732-183X, 8 p.Article

Role of adjuvant chemotherapy in patients with resected non-small-cell lung cancer : Reappraisal with a meta-analysis of randomized controlled trialsHOTTA, Katsuyuki; MATSUO, Keitaro; UEOKA, Hiroshi et al.Journal of clinical oncology. 2004, Vol 22, Num 19, pp 3860-3867, issn 0732-183X, 8 p.Article

Role of early serial change in serum carcinoembryonic antigen levels as a predictive marker for radiological response to gefitinib in japanese patients with non-small cell lung cancerHOTTA, Katsuyuki; KIURA, Katsuyuki; TABATA, Masahiro et al.Anticancer research. 2007, Vol 27, Num 3B, pp 1737-1742, issn 0250-7005, 6 p.Article

Effect of AZD1480 in an epidermal growth factor receptor-driven lung cancer modelMURAKAMI, Toshi; TAKIGAWA, Nagio; KIURA, Katsuyuki et al.Lung cancer. 2014, Vol 83, Num 1, pp 30-36, issn 0169-5002, 7 p.Article

Factor associated with failure to administer subsequent treatment after progression in the first-line chemotherapy in EGFR-mutant non-small cell lung cancer: Okayama Lung Cancer Study Group experienceKATO, Yuka; HOTTA, Katsuyuki; SHINKAI, Tetsu et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 5, pp 943-950, issn 0344-5704, 8 p.Article

Impact of physical size on gefitinib efficacy in patients with non-small cell lung cancer harboring EGFR mutationsICHIHARA, Eiki; HOTTA, Katsuyuki; TANIMOTO, Mitsune et al.Lung cancer. 2013, Vol 81, Num 3, pp 435-439, issn 0169-5002, 5 p.Article

Combination of SN-38 with gefitinib or imatinib overcomes SN-38-resistant small-cell lung cancer cellsTAKIGAWA, Nagio; TAKEYAMA, Masami; FUJIWARA, Yoshiro et al.Oncology reports. 2007, Vol 17, Num 5, pp 983-987, issn 1021-335X, 5 p.Article

Impact of HER2 and EGFR gene status on gefitinib-treated patients with nonsmall-cell lung cancerSOH, Junichi; TOYOOKA, Shinichi; KIURA, Katsuyuki et al.International journal of cancer. 2007, Vol 121, Num 5, pp 1162-1167, issn 0020-7136, 6 p.Article

Influence of the timing of tumor regression after the initiation of chemoradiotherapy on prognosis in patients with limited-disease small-cell lung cancer achieving objective responseFUJII, Masanori; HOTTA, Katsuyuki; TAKIGAWA, Nagio et al.Lung cancer. 2012, Vol 78, Num 1, pp 107-111, issn 0169-5002, 5 p.Article

Gefitinib induces premature senescence in non-small cell lung cancer cells with or without EGFR gene mutationHOTTA, Katsuyuki; TABATA, Masahiro; TANIMOTO, Mitsune et al.Oncology reports. 2007, Vol 17, Num 2, pp 313-317, issn 1021-335X, 5 p.Article

Recent improvement in the survival of patients with advanced nonsmall cell lung cancer enrolled in phase III trials of first-line, systemic chemotherapyHOTTA, Katsuyuki; FUJIWARA, Yoshiro; MATSUO, Keitaro et al.Cancer. 2007, Vol 109, Num 5, pp 939-948, issn 0008-543X, 10 p.Article

The combination effect of amrubicin with cisplatin or irinotecan for small-cell lung cancer cellsTAKIGAWA, Nagio; TAKEYAMA, Masako; KIURA, Katsuyuki et al.Oncology reports. 2006, Vol 15, Num 4, pp 837-842, issn 1021-335X, 6 p.Article

A phase I study and pharmacokinetics of irinotecan (CPT-11) and paclitaxel in patients with advanced non-small cell lung cancerHOTTA, Katsuyuki; UEOKA, Hiroshi; TANIMOTO, Mitsune et al.Lung cancer. 2004, Vol 45, Num 1, pp 77-84, issn 0169-5002, 8 p.Article

Epidermal growth factor receptor mutation, but not sex and smoking, is independently associated with favorable prognosis of gefitinib-treated patients with lung adenocarcinomaTOYOOKA, Shinichi; TAKANO, Toshimi; AOE, Keisuke et al.Cancer science. 2008, Vol 99, Num 2, pp 303-308, issn 1347-9032, 6 p.Article

Isolated metastasis of lung cancer to the thyroid glandOSAWA, Masahiro; TAKIGAWA, Nagio; KIURA, Katsuyuki et al.Lung cancer. 2007, Vol 58, Num 1, pp 156-158, issn 0169-5002, 3 p.Article

Clustered incidence of acute promyelocytic leukemia during gefitinib treatment for non-small-cell lung cancer : Experience at a single institutionMATSUO, Keitaro; KIURA, Katsuyuki; SHINAGAWA, Katsuji et al.American journal of hematology. 2006, Vol 81, Num 5, pp 349-354, issn 0361-8609, 6 p.Article

Identification of epigenetic aberrant promoter Methylation in serum DNA is useful for early detection of lung cancerFUJIWARA, Keiichi; FUJIMOTO, Nobukazu; TANIMOTO, Mitsune et al.Clinical cancer research. 2005, Vol 11, Num 3, pp 1219-1225, issn 1078-0432, 7 p.Article

Progression-free survival and overall survival in phase III trials of molecular-targeted agents in advanced non-small-cell lung cancerHOTTA, Katsuyuki; SUZUKI, Etsuji; HISAMOTO-SATO, Akiko et al.Lung cancer. 2013, Vol 79, Num 1, pp 20-26, issn 0169-5002, 7 p.Article

Usefulness of cumulative smoking dose for identifying the EGFR mutation and patients with non-small-cell lung cancer for gefitinib treatmentJIDA, Masaru; TOYOOKA, Shinichi; OTO, Takahiro et al.Cancer science. 2009, Vol 100, Num 10, pp 1931-1934, issn 1347-9032, 4 p.Article

Serum level of arginine-vasopressin influences the prognosis of extensive-disease small-cell lung cancerUMEMURA, Shigeki; SEGAWA, Yoshihiko; UEOKA, Hiroshi et al.Journal of cancer research and clinical oncology. 2007, Vol 133, Num 8, pp 519-524, issn 0171-5216, 6 p.Article

A phase I study of 3-day topotecan and cisplatin in elderly patients with small-cell lung cancerFUJIWARA, Keiichi; UEOKA, Hiroshi; HARITA, Shingo et al.Cancer chemotherapy and pharmacology. 2006, Vol 57, Num 6, pp 755-760, issn 0344-5704, 6 p.Article